Characteristics of ischemia-induced taurine release in the developing mouse hippocampus

Neuroscience

Volumn 94, Issue 3, 1999, Pages 949-954

  Saransaari, P ^a   Oja, S S ^a,b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Development; Excitotoxicity; Hippocampal slices; Ischemia; Release mechanisms; Taurine release

Indexed keywords

4 ACETAMIDO 4' ISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; AMILORIDE; AMINOPYRIDINE; CHLORIDE ION; NIMODIPINE; PHOSPHOLIPASE INHIBITOR; PROTEIN KINASE INHIBITOR; RILUZOLE; TAURINE;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HIPPOCAMPUS; INHIBITION KINETICS; MALE; MEMBRANE DAMAGE; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; SODIUM TRANSPORT;

EID: 0032825345     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00384-X     Document Type: Article

References (51)

1. Andersen L., Sundman L.-O., Lindén I.-B., Kontro P., Oja S.S. Synthesis and anticonvulsant properties of some 2-aminoethanesulfonic acid (taurine) derivatives. J. pharmac. Sci. 73:1984;106-108.
2. Bouchard R., Fedida D. Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5. J. Pharmac. exp. Ther. 275:1995;864-876.
3. Cherubini E., Ben-Ari Y., Krnjevic K. Anoxia produces smaller changes in synaptic transmission, membrane potential and input resistance in immature rat hippocampus. J. Neurophysiol. 62:1989;882-895.
4. Cook T.M., Crutcher K.A. Intrahippocampal injection of kainic acid produces significant pyramidal cell loss in neonatal rats. Neuroscience. 18:1986;79-92.
5. Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 47:1996;S233-S241.
6. Durkin J.P., Tremblay R., Chakravarthy B., Mealing G., Morley P., Small D., Song D. Evidence that the early loss of membrane protein kinase C is a necessary step in the excitatory amino acid-induced death of primary cortical neurons. J. Neurochem. 68:1997;1400-1412.
7. Fariello R.G., Golden G.T., Pisa M. Homotaurine (3-aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect of systemically administered kainic acid. Neurology. 32:1982;241-245.
8. Ferriero D.M., Arcavi L.J., Simon R.P. Ontogeny of excitotoxic injury to nicotinamide adenine dinucleotide phosphate diaphorase reactive neurons in the neonatal rat striatum. Brain Res. 304:1990;417-424.
9. French E.D., Vezzani A., Whetsell W.O. Jr, Schwarcz R. Antiexcitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv. exp. Med. Biol. 203:1986;349-362.
10. Hamill O.P., McBride D.W. Jr. The pharmacology of mechanogated membrane ion channels. Pharmac. Rev. 48:1996;231-252.
11. Kontro P. Effects of cations on taurine, hypotaurine, and GABA uptake in mouse brain slices. Neurochem. Res. 7:1982;1391-1401.
12. Kontro P., Oja S.S. Sodium dependence of taurine uptake in rat brain synaptosomes. Neuroscience. 3:1978;761-765.
13. Kontro P., Oja S.S. Taurine and GABA release from mouse cerebral cortex slices: potassium stimulation releases more taurine than GABA from developing brain. Devl Brain Res. 37:1987;277-291.
14. Kontro P., Oja S.S. Taurine and GABA release from mouse cerebral cortex slices: effects of structural analogues and drugs. Neurochem. Res. 12:1987;475-482.
15. Kontro P., Oja S.S. Effects of taurine on the influx and efflux of calcium in brain slices of adult and developing mice. Int. J. Neurosci. 38:1988;103-109.
16. Kontro P., Marnela K.-M., Oja S.S. Free amino acids in the synaptosome and synaptic vesicle fractions of different bovine brain areas. Brain Res. 184:1980;129-141.
17. Korpi E.R., Oja S.S. Characteristics of taurine release from cerebral cortex slices induced by sodium-deficient media. Brain Res. 289:1983;197-204.
18. Lehmann A., Hagberg H., Hamberger A. A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation. Neurosci. Lett. 52:1984;341-346.
19. Lehmann A., Hagberg H., Nyström B., Sandberg M., Hamberger A. In vivo regulation of extracellular taurine and other neuroactive amino acids in rabbit hippocampus. Prog. clin. biol. Res. 179:1985;289-311.
20. Magnusson K.R., Clements J.R., Wu J.-Y., Beitz A.J. Colocalization of taurine- and cysteine sulfinic acid decarboxylase-like immunoreactivity in the hippocampus of the rat. Synapse. 4:1989;55-69.
21. Mantz J., Laudenbach V., Lecharny J.-B., Henzel D., Desmonts J.-M. Riluzole, a novel antiglutamate, blocks GABA uptake by striatal synaptosomes. Eur. J. Pharmac. 257:1994;R7-R8.
22. 2+ release. Trends pharmac. Sci. 16:1995;356-359.
23. Oja S.S., Kontro P. Free amino acids in epilepsy: possible role of taurine. Acta neurol. scand. 67:(Suppl. 95):1983;5-20.
24. Oja S. S. and Kontro P. (1983) Taurine. In Handbook of Neurochemistry, 2nd edn (ed. Lajtha A.), Vol. 3, pp. 501-533. Plenum, New York.
25. Oja S.S., Kontro P. Cation effects on taurine release from brain slices: comparison to GABA. J. Neurosci. Res. 17:1987;302-311.
26. Oja S. S. and Korpi E. R. (1985) Amino acid transport. In Handbook of Neurochemistry, 2nd edn (ed. Lajtha A.), Vol. 5, pp. 311-337. Plenum, New York.
27. Oja S.S., Saransaari P. Kinetic analysis of taurine influx into cerebral cortical slices from adult and developing mice in different incubation conditions. Neurochem. Res. 21:1996;161-166.
28. Oja S.S., Korpi E.R., Saransaari P. Modification of chloride flux across brain membranes by inhibitory amino acids in developing and adult mice. Neurochem. Res. 15:1990;797-804.
29. Olney J.W. Role of excitotoxins in developmental neuropathology. APMIS. 101:(Suppl. 40):1993;103-112.
30. O'Regan M.H., Smith-Barbour M., Perkins L.M., Phillis J.W. A possible role for phospholipases in the release of neurotransmitter amino acids from ischemic rat cerebral cortex. Neurosci. Lett. 185:1995;191-194.
31. Palkovits M., Elekes I., Lang T., Patthy A. Taurine levels in discrete brain nuclei of rats. J. Neurochem. 47:1986;1333-1335.
32. Pasantes-Morales H. Volume regulation in brain cells: cellular and molecular mechanisms. Metab. Brain Dis. 11:1996;187-204.
33. Phillis J.W., Song D., O'Regan M.H. Inhibition of tyrosine phosphorylation attenuates amino acid neurotransmitter release from the ischemic/reperfused rat cerebral cortex. Neurosci. Lett. 207:1996;151-154.
34. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
35. Sanchez-Olea R., Morán J., Schousboe A., Pasantes-Morales H. Hyposmolarity-activated fluxes of taurine in astrocytes are mediated by diffusion. Neurosci. Lett. 130:1991;233-236.
36. - transport in cultured astrocytes. Neurosci. Lett. 156:1993;141-144.
37. Sánchez-Prieto J., Sihra T.S., Nicholls D.G. Characterization of the exocytotic release of glutamate from guinea-pig cerebral cortical synaptosomes. J. Neurochem. 49:1987;58-64.
38. Saransaari P., Oja S.S. Release of GABA and taurine from brain slices. Prog. Neurobiol. 38:1992;455-482.
39. Saransaari P., Oja S.S. Taurine and neural cell damage: transport of taurine in adult and developing mice. Adv. exp. Med. Biol. 403:1996;481-490.
40. Saransaari P., Oja S.S. Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus. Neuroscience. 79:1997;847-854.
41. Saransaari P., Oja S.S. Glutamate-agonist-evoked taurine release from the adult and developing mouse hippocampus in cell-damaging conditions. Amino Acids. 9:1997;323-334.
42. Saransaari P., Oja S.S. Release of endogenous glutamate, aspartate, GABA and taurine from hippocampal slices from adult and developing mice in cell-damaging conditions. Neurochem. Res. 23:1998;567-574.
43. Saransaari P., Oja S.S. Cell-damaging conditions release more taurine than excitatory amino acids from the immature hippocampus. Adv. exp. Med. Biol. 442:1998;347-353.
44. Saransaari P., Oja S.S. Mechanisms of ischemia-induced taurine release in mouse hippocampal slices. Brain Res. 807:1998;118-124.
45. Schurr A., Rigor B.M. The mechanism of neuronal resistance and adaptation to hypoxia. Fedn Eur. biochem. Socs Lett. 224:1987;4-8.
46. Schurr A., Tseng M.T., West C.A., Rigor B.M. Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sci. 40:1987;2059-2066.
47. Somjen G.G., Aitken P.G., Balestrino M., Herreras O., Kawasaki K. Spreading depression-like depolarization and selective vulnerability of neurons: brief review. Stroke. 21:1990;179-183.
48. Strange K., Emma F., Jackson P.S. Cellular and molecular physiology of volume-sensitive anion channels. Am. J. Physiol. 270:1996;C711-C730.
49. Taber K.H., Lin C.-T., Liu J.-W., Thalmann R., Wu J.-Y. Taurine in hippocampus: localization and postsynaptic action. Brain Res. 386:1986;113-121.
50. Vanucci R.C. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediat. Res. 27:1990;317-326.
51. Wu J.-Y., Lin C.-T., Johanssen F.F., Liu J.-M. Taurine neurons in rat hippocampal formation are relatively inert to cerebral ischemia. Adv. exp. Med. Biol. 259:1994;289-298.